SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. - Business Insider
4/2/26 at 6:30pm
Organization
Business Insider
Author
Allie Kelly
51 words
0
Comments
The FDA has approved Foundayo, a new weight-loss pill that could give Eli Lilly an edge over other drugmakers. Here's how it compares to other GLP-1s.
Weight Loss
Drugs & Medications
Business & Industrial
Pharmaceuticals & Biotech
Health News
Obesity
You are the first to view
https://www.businessinsider.com/foundayo-vs-zepbound-wegovy-rybelsus-cost-insurance-side-effects-2026-4
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...